EMIS Group (LON:EMISG) is a clinical software supplier to the UK healthcare market. Its strategy is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives. EMIS was originally established to serve the GP market, where it has a leading position with a market share of 57% of UK GP practices. It has expanded from this position to create a broad range of solutions used widely across every major healthcare setting. It operates through two segments: EMIS Health, which supplies innovative integrated care technology to the NHS (including primary, community, acute and social care) and EMIS Enterprise, which is focused on growth in the business-to-business technology sector within the healthcare market, including medicines management, partner businesses, life sciences and patient-facing services.
In this interview, CEO Andy Thorburn reviews the highlights of the group’s performance in FY21, including an update on a divisional basis. He outlines the opportunities for EMIS in connected care and discusses the company’s M&A strategy. Finally, he discusses the current trading environment and outlines how EMIS intends to accelerate growth in the longer term.